FI860305A - 1,6-naftyridin-2(1h)-oner, vilka aer anvaendbara som hjaertmedicin och deras framstaellning. - Google Patents

1,6-naftyridin-2(1h)-oner, vilka aer anvaendbara som hjaertmedicin och deras framstaellning. Download PDF

Info

Publication number
FI860305A
FI860305A FI860305A FI860305A FI860305A FI 860305 A FI860305 A FI 860305A FI 860305 A FI860305 A FI 860305A FI 860305 A FI860305 A FI 860305A FI 860305 A FI860305 A FI 860305A
Authority
FI
Finland
Prior art keywords
hjaertmedicin
oner
naphthyridin
deras framstaellning
och deras
Prior art date
Application number
FI860305A
Other languages
English (en)
Other versions
FI860305A0 (fi
Inventor
George Yohe Lesher
Baldev Singh
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of FI860305A0 publication Critical patent/FI860305A0/fi
Publication of FI860305A publication Critical patent/FI860305A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
FI860305A 1985-01-28 1986-01-22 1,6-naftyridin-2(1h)-oner, vilka aer anvaendbara som hjaertmedicin och deras framstaellning. FI860305A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69560385A 1985-01-28 1985-01-28
US76590085A 1985-08-14 1985-08-14
US81104085A 1985-12-19 1985-12-19

Publications (2)

Publication Number Publication Date
FI860305A0 FI860305A0 (fi) 1986-01-22
FI860305A true FI860305A (fi) 1986-07-29

Family

ID=27418622

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860305A FI860305A (fi) 1985-01-28 1986-01-22 1,6-naftyridin-2(1h)-oner, vilka aer anvaendbara som hjaertmedicin och deras framstaellning.

Country Status (12)

Country Link
EP (1) EP0189853A3 (fi)
KR (1) KR870006046A (fi)
AU (1) AU590870B2 (fi)
DK (1) DK32086A (fi)
ES (1) ES8800221A1 (fi)
FI (1) FI860305A (fi)
GR (1) GR860180B (fi)
IL (1) IL77670A (fi)
NO (1) NO860230L (fi)
NZ (1) NZ214837A (fi)
PH (1) PH22347A (fi)
PT (1) PT81894B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567186A (en) * 1985-01-14 1986-01-28 Sterling Drug Inc. 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415580A (en) * 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same
US4710507A (en) * 1983-12-22 1987-12-01 Pfizer Inc. Quinolone inotropic agents
US4560691A (en) * 1984-07-13 1985-12-24 Sterling Drug Inc. 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation

Also Published As

Publication number Publication date
NZ214837A (en) 1988-10-28
NO860230L (no) 1986-07-29
PH22347A (en) 1988-08-12
EP0189853A2 (en) 1986-08-06
AU590870B2 (en) 1989-11-23
KR870006046A (ko) 1987-07-08
DK32086A (da) 1986-07-29
ES551258A0 (es) 1987-11-01
IL77670A (en) 1989-05-15
EP0189853A3 (en) 1987-12-16
ES8800221A1 (es) 1987-11-01
PT81894B (en) 1987-05-05
GR860180B (en) 1986-05-29
DK32086D0 (da) 1986-01-22
PT81894A (en) 1986-02-01
FI860305A0 (fi) 1986-01-22
AU5244786A (en) 1986-07-31

Similar Documents

Publication Publication Date Title
FI860971A (fi) Nya sulfonylaminoetylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI860232A0 (fi) Tiazolidindionderivat, deras framstaellning och anvaendning.
FI862623A (fi) Nya 2-arylimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI864879A (fi) Nya tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI861153A0 (fi) Nya jodpropargyletrar, foerfarande foer deras framstaellning och deras anvaendning.
FI863630A (fi) Linshaollare, speciellt haollare foer glasoegonlinser som skall renas och daerefter belaeggas.
FI865168A0 (fi) Tillaeggsaemnesfoerening som foerbaettrar kallfloede och braenslekomposition innehaollande densamma.
FI860556A (fi) Nya 1,8-naftyridinderivat och foerfarande foer deras framstaellning.
FI874279A (fi) Daeck foersett med radiell stomfoerstaerkning och med minst en sidovaegg, vilken aer foersedd med en skyddslist.
FI862723A0 (fi) Nya sackarider, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma.
FI860981A0 (fi) Heterocykliska sulfider och deras anvaendning som immunomodulatorer.
FI863537A (fi) Dihydropyridin-2-hydroxyaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI863550A (fi) Ksantinderivator, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI834215A (fi) 2(1h)-pyridinoner och deras framstaellning, anvaendbara som hjaertmediciner.
FI875562A0 (fi) Membran-elektrodkompositstruktur innehaollande banor, som aer foerbundna med varandra och som bestaor av katalytiskt aktiva partiklar.
FI865190A (fi) Nya bensamider, foerfarande foer deras framstaellning och deras terapeutiska anvaendning.
FI860980A0 (fi) Heterocykliska disulfider och deras anvaendning som immunmodulatorer.
FI860305A0 (fi) 1,6-naftyridin-2(1h)-oner, vilka aer anvaendbara som hjaertmedicin och deras framstaellning.
FI862970A0 (fi) Nya 11-metylen-estr-15-ener, foerfaranden foer deras framstaellning och farmaceutiska kompositioner.
FI860866A (fi) Anordning som uppbaer och visar paosar.
FI863644A0 (fi) Foerfarande foer framstaellning av byggnadselement som aer speciellt laempade foer anvaendning som tegelfasader.
FI921219A (fi) Foerfarande foer framstaellning av foereningar, vilka aer anvaendbara vid framstaellning av epipodofyllotoxin och naerliggande foereningar.
FI860128A (fi) Inmatningsroer foer halmbalar och dylika, som emballeras i en folieslang.
FI851315A0 (fi) Foerfarande och anordning foer behandling av fasta aemnespartiklar i en behandlingskanal, som aer foersedd med sil- eller filterytor.
FI852972L (fi) Foerfarande och anordning foer avlaegsnande av orenheter i ett fartyg som aer under byggnad.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: STERLING DRUG, INC.